Aclaris Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Aclaris Therapeutics, Inc. (ACRS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 513.66 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- Aclaris Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 512.16K shares.
- Aclaris Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 1.50K shares, a 95.08% decline year-over-year.
- Aclaris Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 398.27K shares, a 72.84% increase year-over-year.
- Aclaris Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 431.10K shares, a 366.44% increase year-over-year.
- Aclaris Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 859.87K shares, a 59.89% decline from fiscal 2024.
- Aclaris Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 2.14M shares, a 133.49% increase from fiscal 2023.
- Aclaris Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 918.17K shares, a 15.44% decline from fiscal 2022.
- Aclaris Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.09M shares, a 3336.28% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 512.16K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 513.66K shares 10-Q · filed 2026-08-06 | 911.93K shares derived: sum of 3 quarters · filed 2026-08-06 | 1.34M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 1.50K shares 10-Q · filed 2026-05-07 | 399.77K shares derived: sum of 2 quarters · filed 2026-05-07 | 830.87K shares derived: sum of 3 quarters · filed 2026-05-07 | 830.87K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 398.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 829.37K shares derived: sum of 2 quarters · filed 2026-02-26 | 829.37K shares derived: sum of 3 quarters · filed 2026-02-26 | 859.87K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 431.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 431.10K shares derived: sum of 2 quarters · filed 2025-11-06 | 461.60K shares 10-Q · filed 2025-11-06 | 692.03K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 30.50K shares 10-Q · filed 2025-08-07 | 260.93K shares derived: sum of 3 quarters · filed 2026-02-26 | 353.35K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | 30.50K shares 10-Q · filed 2025-05-08 | 260.93K shares derived: sum of 2 quarters · filed 2026-02-26 | 353.35K shares derived: sum of 3 quarters · filed 2026-02-26 | 879.52K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | 230.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 322.85K shares derived: sum of 2 quarters · filed 2026-02-26 | 849.02K shares derived: sum of 3 quarters · filed 2026-02-26 | 2.14M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 92.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 618.60K shares derived: sum of 2 quarters · filed 2024-11-06 | 1.91M shares 10-Q · filed 2024-11-06 | 2.60M shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | 526.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 1.82M shares 10-Q · filed 2024-08-07 | 2.51M shares derived: sum of 3 quarters · filed 2025-02-27 | 2.54M shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | 1.29M shares 10-Q · filed 2024-05-07 | 1.98M shares derived: sum of 2 quarters · filed 2025-02-27 | 2.01M shares derived: sum of 3 quarters · filed 2025-02-27 | 2.01M shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | 689.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 714.73K shares derived: sum of 2 quarters · filed 2025-02-27 | 714.73K shares derived: sum of 3 quarters · filed 2025-02-27 | 918.17K shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 25.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 25.55K shares derived: sum of 2 quarters · filed 2023-11-06 | 228.99K shares 10-Q · filed 2023-11-06 | 460.99K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 203.44K shares 10-Q · filed 2023-08-07 | 435.44K shares derived: sum of 3 quarters · filed 2024-02-27 | 705.53K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-03-31 | 203.44K shares 10-Q · filed 2023-05-08 | 435.44K shares derived: sum of 2 quarters · filed 2024-02-27 | 705.53K shares derived: sum of 3 quarters · filed 2024-02-27 | 918.60K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-12-31 | 232.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 502.09K shares derived: sum of 2 quarters · filed 2024-02-27 | 715.15K shares derived: sum of 3 quarters · filed 2024-02-27 | 1.09M shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 270.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 483.15K shares derived: sum of 2 quarters · filed 2022-11-08 | 853.86K shares 10-Q · filed 2022-11-08 | 859.64K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 213.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | 583.77K shares 10-Q · filed 2022-08-03 | 589.55K shares derived: sum of 3 quarters · filed 2024-02-27 | 604.45K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 370.71K shares 10-Q · filed 2022-05-10 | 376.48K shares derived: sum of 2 quarters · filed 2024-02-27 | 391.38K shares derived: sum of 3 quarters · filed 2024-02-27 | 392.31K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 5.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 20.68K shares derived: sum of 2 quarters · filed 2024-02-27 | 21.60K shares derived: sum of 3 quarters · filed 2024-02-27 | 31.60K shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 14.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 15.82K shares derived: sum of 2 quarters · filed 2021-11-02 | 25.82K shares 10-Q · filed 2021-11-02 | 201.35K shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | 925.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 10.93K shares 10-Q · filed 2021-08-05 | 186.45K shares derived: sum of 3 quarters · filed 2023-02-23 | 365.49K shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | 10.00K shares 10-Q · filed 2021-05-07 | 185.53K shares derived: sum of 2 quarters · filed 2023-02-23 | 364.56K shares derived: sum of 3 quarters · filed 2023-02-23 | 646.70K shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | 175.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 354.56K shares derived: sum of 2 quarters · filed 2023-02-23 | 636.70K shares derived: sum of 3 quarters · filed 2023-02-23 | 911.79K shares 10-K · filed 2023-02-23 |
| 2020-09-30 | 179.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 461.17K shares derived: sum of 2 quarters · filed 2020-11-04 | 736.26K shares 10-Q · filed 2020-11-04 | 1.13M shares derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | 282.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 557.22K shares 10-Q · filed 2020-08-07 | 951.99K shares derived: sum of 3 quarters · filed 2022-02-24 | 1.34M shares derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | 275.09K shares 10-Q · filed 2020-05-07 | 669.86K shares derived: sum of 2 quarters · filed 2022-02-24 | 1.06M shares derived: sum of 3 quarters · filed 2022-02-24 | 1.23M shares derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | 394.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 783.22K shares derived: sum of 2 quarters · filed 2022-02-24 | 953.58K shares derived: sum of 3 quarters · filed 2022-02-24 | 1.08M shares 10-K · filed 2022-02-24 |
| 2019-09-30 | 388.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 558.81K shares derived: sum of 2 quarters · filed 2019-11-07 | 686.81K shares 10-Q · filed 2019-11-07 | 789.98K shares derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | 170.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 298.36K shares 10-Q · filed 2019-08-08 | 401.53K shares derived: sum of 3 quarters · filed 2021-02-25 | 564.27K shares derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | 128.00K shares 10-Q · filed 2019-05-08 | 231.17K shares derived: sum of 2 quarters · filed 2021-02-25 | 393.91K shares derived: sum of 3 quarters · filed 2021-02-25 | 549.88K shares derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | 103.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 265.91K shares derived: sum of 2 quarters · filed 2021-02-25 | 421.88K shares derived: sum of 3 quarters · filed 2021-02-25 | 447.03K shares 10-K · filed 2021-02-25 |
| 2018-09-30 | 162.74K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 318.71K shares derived: sum of 2 quarters · filed 2018-11-06 | 343.85K shares 10-Q · filed 2018-11-06 | 430.53K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | 155.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | 181.12K shares 10-Q · filed 2018-08-03 | 267.79K shares derived: sum of 3 quarters · filed 2020-02-25 | 280.52K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | 25.15K shares 10-Q · filed 2018-05-08 | 111.82K shares derived: sum of 2 quarters · filed 2020-02-25 | 124.56K shares derived: sum of 3 quarters · filed 2020-02-25 | 126.06K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | 86.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 99.41K shares derived: sum of 2 quarters · filed 2020-02-25 | 100.91K shares derived: sum of 3 quarters · filed 2020-02-25 | 126.95K shares 10-K · filed 2020-02-25 |
| 2017-09-30 | 12.73K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 14.23K shares derived: sum of 2 quarters · filed 2017-11-07 | 40.28K shares 10-Q · filed 2017-11-07 | 40.83K shares derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | 1.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 27.55K shares 10-Q · filed 2017-08-08 | 28.10K shares derived: sum of 3 quarters · filed 2019-03-18 | 93.03K shares derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | 26.05K shares 10-Q · filed 2017-05-09 | 26.60K shares derived: sum of 2 quarters · filed 2019-03-18 | 91.53K shares derived: sum of 3 quarters · filed 2019-03-18 | |
| 2016-12-31 | 552.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 65.48K shares derived: sum of 2 quarters · filed 2019-03-18 | 68.11K shares 10-K · filed 2019-03-18 | |
| 2016-09-30 | 64.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 67.56K shares 10-Q · filed 2016-11-03 | ||
| 2016-06-30 | 2.63K shares 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |